These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25142230)

  • 1. Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients.
    Tastekin D; Kargin S; Karabulut M; Yaldız N; Tambas M; Gurdal N; Tatli AM; Arslan D; Gok AF; Aykan F
    Tumour Biol; 2014 Dec; 35(12):11871-7. PubMed ID: 25142230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.
    Guo J; Shou C; Meng L; Jiang B; Dong B; Yao L; Xie Y; Zhang J; Chen Y; Budman DR; Shi YE
    Int J Cancer; 2007 Sep; 121(6):1296-305. PubMed ID: 17534899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
    Winder AD; Maniar KP; Wei JJ; Liu D; Scholtens DM; Lurain JR; Schink JC; Buttin BM; Filiaci VL; Lankes HA; Ramirez NC; Park K; Singh M; Lieberman RW; Mannel RS; Powell MA; Backes FJ; Mathews CA; Pearl ML; Secord AA; Peace DJ; Mutch DG; Creasman WT; Kim JJ
    Cancer; 2017 Apr; 123(7):1144-1155. PubMed ID: 27926776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease.
    Strohl A; Mori K; Akers S; Bshara W; Buttin B; Frederick PJ; Helenowski IB; Morrison CD; Odunsi K; Schink JC; Scholtens DM; Wei JJ; Kim JJ
    J Ovarian Res; 2016 Nov; 9(1):75. PubMed ID: 27809878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen.
    Liu C; Dong B; Lu A; Qu L; Xing X; Meng L; Wu J; Eric Shi Y; Shou C
    BMC Cancer; 2010 Jul; 10():359. PubMed ID: 20604972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between periostin and SNCG and esophageal cancer invasion, infiltration and apoptosis.
    Luo JH; Zhou J; Gao Y
    Asian Pac J Trop Med; 2013 Jul; 6(7):516-9. PubMed ID: 23768821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma.
    Takemura Y; Ojima H; Oshima G; Shinoda M; Hasegawa Y; Kitago M; Yagi H; Abe Y; Hori S; Fujii-Nishimura Y; Kubota N; Masuda Y; Hibi T; Sakamoto M; Kitagawa Y
    Cancer Med; 2021 Aug; 10(16):5599-5613. PubMed ID: 34245137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients.
    Min L; Zhang C; Ma R; Li X; Yuan H; Li Y; Chen R; Liu C; Guo J; Qu L; Shou C
    BMC Cancer; 2016 Sep; 16(1):717. PubMed ID: 27595752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancer.
    Wu K; Huang S; Zhu M; Lu Y; Chen J; Wang Y; Lin Q; Shen W; Zhang S; Zhu J; Shi YE; Weng Z
    Med Oncol; 2013; 30(3):612. PubMed ID: 23696021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
    Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
    Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined expression of metastasis related markers Naa10p, SNCG and PRL-3 and its prognostic value in breast cancer patients.
    Min L; Ma RL; Yuan H; Liu CY; Dong B; Zhang C; Zeng Y; Wang L; Guo JP; Qu LK; Shou CC
    Asian Pac J Cancer Prev; 2015; 16(7):2819-26. PubMed ID: 25854368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [SNCG expression and clinical significance in colorectal cancer liver metastasis].
    Guo CG; Sun LC; Liu Q; Xie YB; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jun; 15(6):625-8. PubMed ID: 22736138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive Detection of Esophageal Cancer by the Combination of mSEPT9 and SNCG.
    Zhang L; Yang X; Tian Y; Yu Q; Zhou D; Wu Z; Zhao X
    Genet Test Mol Biomarkers; 2022 Jan; 26(1):8-16. PubMed ID: 35089073
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined phenotype of 4 markers improves prognostic value of patients with colon cancer.
    Liu C; Qu L; Dong B; Xing X; Ren T; Zeng Y; Jiang B; Meng L; Wu J; Shou C
    Am J Med Sci; 2012 Apr; 343(4):295-302. PubMed ID: 22261620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer.
    Czekierdowski A; Czekierdowska S; Wielgos M; Smolen A; Kaminski P; Kotarski J
    Neuro Endocrinol Lett; 2006 Jun; 27(3):381-6. PubMed ID: 16816827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.
    Mhawech-Fauceglia P; Wang D; Syriac S; Godoy H; Dupont N; Liu S; Odunsi K
    Gynecol Oncol; 2012 Jan; 124(1):148-52. PubMed ID: 22015044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of γ-synuclein as a stage-specific marker in bladder cancer by immunohistochemistry.
    Zhao J; Xing N
    Med Sci Monit; 2014 Dec; 20():2550-5. PubMed ID: 25479371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers.
    Liu H; Liu W; Wu Y; Zhou Y; Xue R; Luo C; Wang L; Zhao W; Jiang JD; Liu J
    Cancer Res; 2005 Sep; 65(17):7635-43. PubMed ID: 16140929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration.
    Zhao W; Liu H; Liu W; Wu Y; Chen W; Jiang B; Zhou Y; Xue R; Luo C; Wang L; Jiang JD; Liu J
    Int J Oncol; 2006 May; 28(5):1081-8. PubMed ID: 16596223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural protein gamma-synuclein interacting with androgen receptor promotes human prostate cancer progression.
    Chen J; Jiao L; Xu C; Yu Y; Zhang Z; Chang Z; Deng Z; Sun Y
    BMC Cancer; 2012 Dec; 12():593. PubMed ID: 23231703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.